BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 38505606)

  • 1. H-ferritin-nanocaged gadolinium nanoparticles for ultra-sensitive MR molecular imaging.
    Zhang J; Yuan C; Kong L; Zhu F; Yuan W; Zhang J; Hong J; Deng F; Chen Q; Chen C; Wang T; Zuo Z; Liang M
    Theranostics; 2024; 14(5):1956-1965. PubMed ID: 38505606
    [No Abstract]   [Full Text] [Related]  

  • 2. Target-switchable Gd(III)-DOTA/protein cage nanoparticle conjugates with multiple targeting affibody molecules as target selective T
    Kim H; Jin S; Choi H; Kang M; Park SG; Jun H; Cho H; Kang S
    J Control Release; 2021 Jul; 335():269-280. PubMed ID: 34044091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of Stable Chelate-free Gadolinium Loaded Titanium Dioxide Nanoparticles for MRI-Guided Radionuclide Stimulated Cancer Treatment.
    Fang L; Huang H; Quirk JD; Zheng J; Shen D; Manion B; Mixdorf M; Karmakar P; Sudlow GP; Tang R; Achilefu S
    Curr Anal Chem; 2022 Aug; 18(7):826-835. PubMed ID: 36561765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual T
    Xu L; Hong SH; Sun Y; Sun Z; Shou K; Cheng K; Chen H; Huang D; Xu H; Cheng Z
    Nanomedicine; 2018 Aug; 14(6):1743-1752. PubMed ID: 29679743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A small MRI contrast agent library of gadolinium(III)-encapsulated supramolecular nanoparticles for improved relaxivity and sensitivity.
    Chen KJ; Wolahan SM; Wang H; Hsu CH; Chang HW; Durazo A; Hwang LP; Garcia MA; Jiang ZK; Wu L; Lin YY; Tseng HR
    Biomaterials; 2011 Mar; 32(8):2160-5. PubMed ID: 21167594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New dual mode gadolinium nanoparticle contrast agent for magnetic resonance imaging.
    Ghaghada KB; Ravoori M; Sabapathy D; Bankson J; Kundra V; Annapragada A
    PLoS One; 2009 Oct; 4(10):e7628. PubMed ID: 19893616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving the MR Imaging Sensitivity of Upconversion Nanoparticles by an Internal and External Incorporation of the Gd(3+) Strategy for in Vivo Tumor-Targeted Imaging.
    Du H; Yu J; Guo D; Yang W; Wang J; Zhang B
    Langmuir; 2016 Feb; 32(4):1155-65. PubMed ID: 26740341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineered magnetic hybrid nanoparticles with enhanced relaxivity for tumor imaging.
    Aryal S; Key J; Stigliano C; Ananta JS; Zhong M; Decuzzi P
    Biomaterials; 2013 Oct; 34(31):7725-32. PubMed ID: 23871540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving Longitudinal Transversal Relaxation Of Gadolinium Chelate Using Silica Coating Magnetite Nanoparticles.
    Xu K; Liu H; Zhang J; Tong H; Zhao Z; Zhang W
    Int J Nanomedicine; 2019; 14():7879-7889. PubMed ID: 31576129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-Microenvironment Relaxivity-Changeable Gd-Loaded Poly(L-lysine)/Carboxymethyl Chitosan Nanoparticles as Cancer-Recognizable Magnetic Resonance Imaging Contrast Agents.
    Jiang D; Zhang X; Yu D; Xiao Y; Wang T; Su Z; Liu Y; Zhang N
    J Biomed Nanotechnol; 2017 Mar; 13(3):243-54. PubMed ID: 29381026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. γ-Glutamyltranspeptidase-Triggered Intracellular Gadolinium Nanoparticle Formation Enhances the T
    Hai Z; Ni Y; Saimi D; Yang H; Tong H; Zhong K; Liang G
    Nano Lett; 2019 Apr; 19(4):2428-2433. PubMed ID: 30856326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanotemplate-engineered nanoparticles containing gadolinium for magnetic resonance imaging of tumors.
    Zhu D; Lu X; Hardy PA; Leggas M; Jay M
    Invest Radiol; 2008 Feb; 43(2):129-40. PubMed ID: 18197065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted Molecular Iron Oxide Contrast Agents for Imaging Atherosclerotic Plaque.
    Evans RJ; Lavin B; Phinikaridou A; Chooi KY; Mohri Z; Wong E; Boyle JJ; Krams R; Botnar R; Long NJ
    Nanotheranostics; 2020; 4(4):184-194. PubMed ID: 32637296
    [No Abstract]   [Full Text] [Related]  

  • 14. Enhancing T
    Marangoni VS; Neumann O; Henderson L; Kaffes CC; Zhang H; Zhang R; Bishnoi S; Ayala-Orozco C; Zucolotto V; Bankson JA; Nordlander P; Halas NJ
    Proc Natl Acad Sci U S A; 2017 Jul; 114(27):6960-6965. PubMed ID: 28630340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of an Effective Tumor-Targeted Contrast Agent for Magnetic Resonance Imaging Based on Mn/H-Ferritin Nanocomplexes.
    Tullio C; Salvioni L; Bellini M; Degrassi A; Fiandra L; D'Arienzo M; Garbujo S; Rotem R; Testa F; Prosperi D; Colombo M
    ACS Appl Bio Mater; 2021 Nov; 4(11):7800-7810. PubMed ID: 34805780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide targeted tripod macrocyclic Gd(III) chelates for cancer molecular MRI.
    Zhou Z; Wu X; Kresak A; Griswold M; Lu ZR
    Biomaterials; 2013 Oct; 34(31):7683-93. PubMed ID: 23863450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lumazine Synthase Protein Nanoparticle-Gd(III)-DOTA Conjugate as a T1 contrast agent for high-field MRI.
    Song Y; Kang YJ; Jung H; Kim H; Kang S; Cho H
    Sci Rep; 2015 Oct; 5():15656. PubMed ID: 26493381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human aortic endothelial cell labeling with positive contrast gadolinium oxide nanoparticles for cellular magnetic resonance imaging at 7 Tesla.
    Loai Y; Sakib N; Janik R; Foltz WD; Cheng HL
    Mol Imaging; 2012 Apr; 11(2):166-75. PubMed ID: 22469244
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.